A brain protein reverses aging signs in mice

The protein is called Menin. It is already known as a suppressor of certain tumors, but new research suggests it also plays a role in normal aging. The researchers studied what happens in mice as Menin levels decline with age. They found a broad range of age-related changes that coincide with lower Menin concentrations.

By artificially restoring Menin, they were able to reverse several of those changes. These are preliminary findings in animal models, and the underlying mechanism is not yet fully understood. The researchers suggest that Menin is involved in regulating inflammatory signals and the balance between cellular senescence (a state where cells stop dividing and accumulate) and cellular repair.

D-serine and cognition

A separate finding concerns D-serine, an amino acid that occurs naturally in the brain. Administering D-serine improved cognitive function in the older mice in this study. The precise relationship with Menin remains unclear. The researchers regard this as a separate line of inquiry warranting further investigation.

It is important to note that this is mouse research. Whether the findings translate to humans is unknown. Menin as a therapeutic target in humans has not yet been tested in clinical trials in this context.

Why this is notable

What stands out about this study is the breadth of effects: a single protein appears to contribute to aging processes across multiple tissues simultaneously. This fits a broader hypothesis in aging science, that shared regulators drive multiple aspects of aging at once. Menin is a candidate for that role, though it is too early to draw strong conclusions.

From a longevity perspective, proteins that broadly influence aging are attractive research targets precisely because they may address multiple systems at once.

Read the original article